Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cancer Invest. 2021 Feb;39(2):144-152. doi: 10.1080/07357907.2020.1865396. Epub 2021 Jan 8.
Among 84,447 radiotherapy (RT) courses for Medicare beneficiaries age ≥ 65 with prostate cancer treated with external beam RT (EBRT), brachytherapy, or both, 42,608 (51%) were delivered in hospital-affiliated and 41,695 (49%) in freestanding facilities. Freestanding centers were less likely to use EBRT + brachytherapy than EBRT (OR 0.84 [95%CI 0.84-0.84]; < .001). Treatment was more costly in freestanding centers (mean difference $2,597 [95%CI $2,475-2,719]; < .001). Adjusting for modality and fractionation, RT in hospital-affiliated centers was more costly (mean difference $773 [95%CI $693-853]; < .001). Freestanding centers utilized more expensive RT delivery, but factors unrelated to RT modality or fractionation rendered RT more costly at hospital-affiliated centers.
在为年龄≥65 岁的 Medicare 受益人的前列腺癌接受外部束放射治疗 (EBRT)、近距离放射治疗或两者联合治疗的 84447 例放射治疗 (RT) 课程中,42608 例 (51%) 在医院附属机构进行,41695 例 (49%) 在独立机构进行。与 EBRT 相比,独立中心使用 EBRT+近距离放射治疗的可能性较小(OR 0.84 [95%CI 0.84-0.84];<.001)。独立中心的治疗费用更高(平均差异为 2597 美元 [95%CI 2475-2719];<.001)。在调整了治疗方式和分割方式后,医院附属中心的 RT 费用更高(平均差异为 773 美元 [95%CI 693-853];<.001)。独立中心使用了更昂贵的 RT 治疗,但与 RT 方式或分割无关的因素导致医院附属中心的 RT 费用更高。